Allergy Therapeutics PLC has received a notification of major holdings from Abbott Laboratories, an Illinois corporation. The notification states that Abbott Laboratories, along with Yissum Holding Limited and Abbott Laboratories (Chile) Holdco SpA, collectively hold below 3% of the voting rights in Allergy Therapeutics. This is a decrease from their previous position of 5.06% of the voting rights. The total number of voting rights held by Abbott Laboratories and its affiliates is 0. The notification also confirms that Abbott Laboratories is not controlled by any natural person or legal entity and does not control any other undertakings holding an interest in Allergy Therapeutics. The notification was completed in Chicago, Illinois, United States of America.